Celldex Therapeutics Presents Positive Data from CDX-0159 Phase 1b Study in Chronic Inducible Urticaria at EAACI 2021

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. PANW
3. CL
4. SNDK
5. TAP
6. DELL
7. ROIV
8. ANET
9. NKE
10. SPG

Go back to Celldex Therapeutics Presents Positive Data from CDX-0159 Phase 1b Study in Chronic Inducible Urticaria at EAACI 2021
CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) Delayed: 39.68 +0.31 (0.79%)
Previous Close $39.37    52 Week High $18.62 
Open $38.96    52 Week Low $2.85 
Day High $39.81    P/E N/A 
Day Low $38.90    EPS $-1.02 
Volume 414,533